The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson’s disease
Objective: To examine the contributions of systemic factors to clinically relevant cognitive decline in Parkinson’s disease (PD), we studied the impact of cardiometabolic and inflammatory…Smell and taste in cervical dystonia: a contribution to understand dystonia pathophysiology.
Objective: To contribute to the better understanding of the pathophysiology of cervical dystonia (CD) we systematically assessed olfactory and gustatory functioning in CD subjects and…Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese
Objective: The aim of this study was to compare the efficiency of the short form of Montreal Cognitive Assessment (s-MoCa) which has been validated in…Procedural Memory Changes of Parkinson’s Disease Patients Post Participation in Boxing
Objective: Can participation in a Rock Study Boxing program improve procedural memory in people with Parkinson’s disease (PD)? Background: Procedural memory is important for daily…Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden
Objective: To investigate whether a computerized neuropsychological assessment can detect subtle cognitive impairment associated with Aβ pathology in Parkinson’s disease (PD). Background: Parenchymal Aβ pathology…Specific SLC6A3 variant shows association with better memory in PD patients longitudinally
Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…Accuracy of the MoCA in Detecting PD-MCI in the Ontario Neurodegenerative Disease Research Initiative study
Objective: To investigate the ability of the Montreal Cognitive Assessment (MoCA) to detect mild cognitive impairment (MCI) in Parkinson’s disease (PD) using variations in cognitive…Phosphodiesterase 10A and cognition in Parkinson’s disease
Objective: We aimed to assess the associations between Phosphodiesterase 10A (PDE10A) expression in the executive striatum and cognitive performance in vivo, using [11C]IMA107 PET and…The Dutch Parkinson and Cognition study (DUPARC): Cognitive impairment and cholinergic innervation in de novo Parkinson’s Disease patients
Objective: To explore the incidence and characteristics of early cognitive impairment in Parkinson’s disease (PD) patients and the relationship with regional cholinergic innervation. Background: Cognitive…Freezing of Gait in Parkinson’s Disease: Risk Factors and Associated Nonmotor Symptoms
Objective: To clarify risk factors for, and clinical associations of, freezing of gait (FOG) in Parkinson's disease (PD). Background: FOG is a disabling and incompletely…
- « Previous Page
- 1
- …
- 76
- 77
- 78
- 79
- 80
- …
- 128
- Next Page »